Is Venous to Arterial Conversion (v-TAC) of Blood Gas Reliable in Critical Ill Patients in the ICU?
Launched by AALBORG UNIVERSITY · Oct 12, 2017
Trial Information
Current as of September 12, 2025
Unknown status
Keywords
ClinConnect Summary
Arterial blood gas (ABG) analysis is essential in assessment of respiratory and metabolic status in acutely ill patients. In comparison to peripheral venous blood (PVG) sampling, the ABG sampling procedure is more painful for the patient and technically more challenging for the clinician to perform. Other drawbacks of ABG sampling include adverse events such as subcutaneous hematoma, arterial thrombosis or embolization, and pseudoaneurysms.
Peripheral venous blood gas (VBG) sampling has been suggested as an alternative to the ABG procedure. This procedure causes less patient discomfort and...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * All patients admitted to the intensive care with the following:
- • Arterial catheter for other purpose.
- • Peripheral venous catheter or central venous catheter for other purpose.
- Exclusion Criteria:
- • Normal pH in arterial blood gas.
About Aalborg University
Aalborg University is a leading research institution based in Denmark, renowned for its innovative approach to education and research in engineering, natural sciences, and health sciences. With a commitment to advancing knowledge and improving public health outcomes, Aalborg University actively engages in clinical trials that explore cutting-edge medical solutions and interventions. The university fosters interdisciplinary collaboration, leveraging its expertise to enhance clinical research methodologies and contribute to the development of evidence-based practices in healthcare. Through its rigorous scientific inquiry and dedication to ethical standards, Aalborg University plays a pivotal role in shaping the future of health research and improving patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aalborg, North Denmark, Denmark
Patients applied
Trial Officials
Peter Leutscher
Study Director
Professor, Center for Clinical Research
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials